Steven Cohen Supernus Pharmaceuticals, Inc. Put Options Transaction History

Point72 Asset Management, L.P.

  • $40.1 Billion
  • Q1 2025

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$30.84 - $49.51 $1.82 Million - $2.92 Million
-58,900 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$42.7 - $56.55 $12.4 Million - $16.5 Million
-291,100 Reduced 83.17%
58,900 $2.97 Million
Q2 2018

Aug 14, 2018
BUY
$44.1 - $59.85 $15.4 Million - $20.9 Million
350,000 New
350,000 $20.9 Million

Others Institutions Holding SUPN

# of Institutions
305
Shares Held
60.8M
Call Options Held
8.8K
Put Options Held
6.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.73B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email